Westpac Banking Corp Purchases Shares of 33,068 Merck KGaA $MKGAF

Westpac Banking Corp purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 33,068 shares of the company’s stock, valued at approximately $4,249,000.

Several other large investors also recently modified their holdings of MKGAF. Frazier Financial Advisors LLC bought a new stake in shares of Merck KGaA in the 2nd quarter valued at $25,000. Rakuten Securities Inc. bought a new position in Merck KGaA during the second quarter worth $27,000. Bard Associates Inc. bought a new position in Merck KGaA during the second quarter worth $60,000. Kilter Group LLC acquired a new stake in Merck KGaA in the second quarter worth $62,000. Finally, Addison Advisors LLC bought a new stake in Merck KGaA in the second quarter valued at $90,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Stock Performance

Shares of MKGAF opened at $163.21 on Friday. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The company has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The stock has a 50-day moving average of $162.62 and a 200-day moving average of $148.46. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.